Medication info

Double One Tablet

Prescription medicationOralApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tabletTripotassium Bismuth Dicitrate›200mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Green oblong film-coated triple tablet
Packaging
30 tablets, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201506749 · Approved 2015.09.24

This product's status changed to Approval withdrawn on 2025.02.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers and Zollinger-Ellison syndrome) and prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher rate of healing may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded particularly well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily at bedtime. However, the dose may be increased to 2 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. For severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers and Zollinger-Ellison syndrome) and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
View approved original text

This medication is used to treat ulcers of the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and other gastrointestinal diseases. It alleviates the symptoms of gastroesophageal reflux disease and helps to prevent postoperative ulcers. It is also effective in preventing ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used preoperatively to prevent Mendelson's syndrome. Thus, it is used to treat and prevent various gastrointestinal-related symptoms.

How to take

Adult dose

○ Adults The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher rate of healing may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded particularly well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily at bedtime. However, the dose may be increased to 2 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. For severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Precautions

This medication should not be used by patients with severely impaired kidney function or those undergoing dialysis. Additionally, patients with a known allergy to this medication or its components should avoid its use. Patients with a history of acute porphyria, a rare blood disorder, should also refrain from using this medication. It is not recommended for patients who have undergone upper gastrointestinal surgery, pregnant women or women who may become pregnant, and premature or newborn infants. Patients on a potassium-restricted diet should also exercise caution. This medication should be used with caution in patients with liver dysfunction, those with a history of drug allergies, elderly patients, and those with a history of kidney problems. When taken in conjunction with NSAIDs, there is a particular risk of gastrointestinal bleeding, so regular monitoring is required. Since it may mask gastric cancer symptoms, patients with gastric ulcers or new dyspepsia symptoms over the age of 40 should confirm there are no malignant conditions before use. Patients with gastric and duodenal ulcers caused by Helicobacter pylori infection should undergo eradication therapy concurrently. Severely ill ICU patients are at risk of fecalith formation and should be monitored closely. Patients with hypophosphatemia should be cautious as the aluminum component of this medication can hinder phosphate absorption. Those with swallowing difficulties should use this medication with caution due to the risk of respiratory complications. This medication can rarely cause severe allergic reactions or anaphylactic shock, so if any abnormal symptoms occur during use, treatment should be stopped immediately and medical assistance sought. Skin rash, hives, angioedema, fever, bronchospasm, and other hypersensitivity reactions may also occur, and it is important to discontinue treatment if these appear. Blood tests may show leukopenia, thrombocytopenia, or liver function abnormalities, so consult a doctor immediately if any unusual symptoms occur. Arrhythmias or abnormal heart rhythms have been reported infrequently, so patients with heart conditions should exercise caution. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, with stool color sometimes turning black, though this is due to the medication's effect and does not require separate treatment. Severe dizziness, drowsiness, confusion, and seizures may rarely occur as neurological side effects, necessitating immediate discontinuation if these symptoms arise. Gynecomastia, increased milk secretion, and erectile dysfunction have also been reported very rarely, though causality is not clear. Myalgia and arthralgia may occur, and rhabdomyolysis, a severe muscle disease, can rarely manifest, necessitating immediate cessation if symptoms present themselves. Skin rashes, hair loss, and other symptoms of itching have also been reported. Long-term use of this medication is not recommended, and it is important to use the minimum effective dose while closely monitoring treatment progress. Elderly patients or those with chronic lung disease, diabetes, and weakened immunity are at increased risk of pneumonia and should be monitored closely. Additionally, if dizziness or drowsiness occurs while taking this medication, avoid driving or operating hazardous machinery. There may be drug interactions, so patients on anticoagulants or certain antibiotics and anticonvulsants should consult their physicians. When taking medications such as sucralfate, it's advisable to take them at different times. Pregnant or nursing women should not use this medication, and safety in children has not been established, so its use is not recommended. In case of overdose, measures such as vomiting or gastric lavage may be necessary, and in severe cases, dialysis may be required to remove the drug. This medication may reduce gastric acid secretion, potentially promoting bacterial growth in the gastrointestinal tract, so ocular examination may be necessary with prolonged use.

Side effects

  • anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 64 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • bone marrow suppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal bloating
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • sense of heaviness in the head
  • illness sense
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorder
  • hypertonic muscle cramps
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. Proper storage helps to preserve the potency of the medication for a longer period.

Appearance and packaging

Appearance

Green oblong film-coated triple tablet

Package unit

30 tablets, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.